期刊文献+

溃疡性结肠炎患者血浆同型半胱氨酸和叶酸及维生素B12的检测水平及其临床意义 被引量:11

Significance of plasmic homocysteine, folate and Vitamin B12 in ulcerative colitis
原文传递
导出
摘要 目的探讨溃疡性结肠炎(UC)患者中血浆同型半胱氨酸(Hcy)、叶酸(FA)和维生素B12(VitB12)水平的改变及其临床意义。方法采用高效液相荧光检测法(HPLC—FD)检测112例UC患者和110名健康对照人群血浆Hcy水平.应用ELISA方法检测76例UC患者和12名健康对照人群血浆FA和VitB12水平。结果UC患者中血浆Hcy水平为(11.27±7.26)μmol/L,明显高于对照组的(8.19±4.81)μmol/L(P〈0.01);UC患者中血浆Hcy水平与UC病情分度、病变范围及病程均无关(P〉0.05)。UC患者中血浆FA和VitB12水平分别为(7.64±1.95)nmol/L和(108.64±32.22)pmol/L,明显低于对照组[(9.14±1.23)nmol/L和(112.64±33.33)pmol/L,均P〈0.01]。高Hcy组患者血浆FA和VitB12水平显著低于低Hcy组(P〈0.05)。UC患者中血浆FA水平与UC病程呈负相关(P〈0.01);而VitB12水平则与病程无相关性(P〉0.221)。结论UC患者血浆Hcy水平升高,可能与FA和VitB12水平下降有关。 Objective To investigate the clinical significance of plasmic homocysteine (Hcy), folate (FA) and Vitamin B12 (VitB12) in patients with ulcerative colitis (UC). Methods Plasmic Hcy in 112 cases of UC patients and 110 controls were detected by HPLC-FD method. Plasmic FA, VitB12 in 76 cases of UC patients and 12 controls were detected by enzyme-linked immunosorbent assay (ELISA) method. Results The level of plasmic Hey in UC patients was (11.27±7.26) μmol/L, significantly higher than that in controls [ (8.19±4.81) μmol/L, P〈0.05], and was not significantly correlated with disease index, extent and duration of UC (P〉0.05). The level of FA and VitB12 in UC patients were (7.64±1.95) nmol/L and (108.64±32.22) pmol/L respectively, lower than those in controls [ (9.14± 1.23) nmol/L and (112.64±33.33) pmol/L,P〈0.05]. The level of plasmie Hcy was negatively correlated with the level of FA and VitB12 in UC patients (P〈0.05). The level of plasmic FA decreased to some extent with UC disease duration. Conclusion Plasmie Hey is elevated in UC patients, which may be related to the decrease of FA and VitB12.
出处 《中华胃肠外科杂志》 CAS 北大核心 2011年第3期185-187,共3页 Chinese Journal of Gastrointestinal Surgery
关键词 溃疡性结肠炎 同型半胱氨酸 叶酸 维生素B12 Ulcerative colitis Homocysteine Folate Vitamin B12
  • 相关文献

参考文献13

  • 1汪建平.克罗恩病的流行病学及外科治疗[J].中华胃肠外科杂志,2007,10(3):199-201. 被引量:8
  • 2Erzin Y, U zun H, Celik AF, et al. Hyperhomocysteinemia in inflammatory bowel disease patients without past intestinal resections : Correlations with eobalamin, pyridoxine, folate concentrations, acute phase reactants, disease activity, and prior thromboembolic complications. J Clin Gastroenterol, 2008,42(5) :481-486.
  • 3Mahmood A, Needham J, Prosser J, et al. Prevalence of hyperhomocysteinemia, activated protein C resistance and prothrombin gene mutation in inflammatory bowel disease. Eur J Gastroenterol Hepatol, 2005,17 (7) : 739-744.
  • 4Mouelhi L, Mekki H, Debbeche R, et al. Thrombosis in inflammatory bowel disease: mechanisms and risk factors. Tunis Med, 2009,87(5) :307-310.
  • 5Stipanuk MH. Sulfur amino acid metabolism: Pathways for production and removal of homocysteine and cysteine. Annu Rev Nutr, 2004,24(7) :539-577.
  • 6Heijier MD, Rosendaal FR, Blom H J, et al. Hyperhomocysteinemia and venous thrombosis: A meta-analysis. Thromb Haemost, 1998,80(9) :874-877.
  • 7中华医学会消化病学分会炎症性肠病协作组,欧阳钦,胡品津,钱家鸣,郑家驹,胡仁伟.对我国炎症性肠病诊断治疗规范的共识意见(2007年,济南)[J].中华消化杂志,2007,27(8):545-550. 被引量:1020
  • 8Sawula W, Banecka-Majkutewicz Z, Kadzinski L, et al. Improved HPLC method for total plasma homocysteine detection and quantification. Acta Biuchim Pol, 2008,55 ( 1 ) : 119-125.
  • 9Roblin X, Germain E, Phelip JM, et al. Factors associated with hyperhomocysteinemia in inflammatory bowel disease : prospective study in 81 patients. Rev Med Interne, 2006,27 (2) : 106-110.
  • 10Fernandez-Miranda C, Martinez Prieto M, Casis Herce B, et al. Hyperhomocysteinemia and methylenetetrahydrofolate reductase 677C→T and 1298A→C mutations in patients with inflammatory bowel disease. Rev Esp Enferm Dig, 2005,97 (7) :497-504.

二级参考文献17

  • 1Annika Lapidus.Crohn's disease in Stockholm County during 1990-2001:An epidemiological update[J].World Journal of Gastroenterology,2006,12(1):75-81. 被引量:10
  • 2潘国宗 刘彤华 见:潘国宗 曹世植9. 主编.溃疡性结肠炎[A].见:潘国宗,曹世植9.,主编.现代胃肠病学.第Ⅰ版[C].北京:科学出版社,1994.1246-1247.
  • 3潘国宗 刘彤华.Crohn病[A].见:潘国宗 曹世植 主编.现代胃肠病学[C].北京:科学出版社,1994.1154.
  • 4樋渡信夫 渡边浩光 前川浩树 等.溃疡性结肠炎的诊断标准与诊断进展[J].炎症性肠疾患胃与肠,1997,32(3):271-278.
  • 5欧阳钦.炎症性肠病的诊治进展.见:孟宪镛主编.实用消化病诊疗学.第2版.上海:世界图书出版社,2006.362-84.
  • 6Ouyang Q, Tandon R, Goh KL, et al. The emergence of inflammatory bowel disease in the Asian Pacific region. Curr Opin Gastroenterol,2005: 21:408-413.
  • 7Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, con sensus, and implications. Gut, 2006, 55:749-753.
  • 8Zheng JJ. Clinical aspects of ulcerative colitis in China's Mainland. Chin J Dig Dis, 2006, 7:71-75.
  • 9Hanauer SB, Sandborn W, Practice Parameters Committee of the American College of Gastroenterology. Management of Crohn's disease in adults. Am J Gastroenterol, 2001, 96: 635- 643.
  • 10Stange EF, Travis SP, Vermeire S, et al. European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. Gut, 2006, 55 Suppl 1:i1- i15.

共引文献1026

同被引文献84

引证文献11

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部